Ads
related to: prostate cancer in older males photos and names- Oral Medication
Learn More About An Oral Treatment
For Metastatic Prostate Cancer.
- Side Effect Information
Learn More About Potential Side
Effects And Safety Information.
- Genomic Testing
Read How Testing Could
Help Inform Your Treatment Plan.
- Patient Support Program
Learn About A Treatment Option
And Patient Support.
- Oral Medication
Search results
Results From The WOW.Com Content Network
Prostate cancer is a form of cancer that is typically slow-growing and originates in or on the prostate, a male reproductive gland that surrounds the urethra in proximity of the bladder and rectum. This is a result of malignant cells forming and multiplying at the prostate, which can then spread or metastasize to other organs in the body. [1]
Prostate cancer is the most diagnosed cancer in men in over half of the world's countries, and the leading cause of cancer death in men in around a quarter of countries. [91] Prostate cancer is rare in those under 40 years old, [92] and most cases occur in those over 60 years, [2] with the average person diagnosed at 67. [93]
Prostate cancer is one of the most common cancers affecting older men in the UK, US, Northern Europe and Australia, and a significant cause of death for elderly men worldwide. [33] Often, a person does not have symptoms; when they do occur, symptoms may include urinary frequency, urgency, hesitation and other symptoms associated with BPH.
A young patient with an “aggressive-looking” prostate cancer, whose father had the condition and who carries a BRCA2 mutation, is an entirely different patient from “an 80-year-old man who ...
There are several reasons why PIN is the most likely prostate cancer precursor. [3] PIN is more common in men with prostate cancer. High grade PIN can be found in 85 to 100% of radical prostatectomy specimens, [4] nearby or even in connection with prostate cancer. It tends to occur in the peripheral zone of the prostate.
In men aged 55–69 who have been counseled on the known harms and potential benefits of prostate cancer screening, the U.S. Preventive Service Task Force May 2018 statement states, "The use of digital rectal examination as a screening modality is not recommended because there is a lack of evidence on the benefits."